Skip to main content
. 2019 May 24;13:1773–1790. doi: 10.2147/DDDT.S196276

Table 3.

Analgesic activity using tail-flick test for tested compounds

Latency (seconds) Potency (%)
0 minutes 30 minutes 60 minutes 120 minutes
Control 3.2±0.4 4.1±0.4b 4.1±0.3b 4.0±0.2b
Naproxen 3.5±0.6 5.3±0.3a 6.2±0.4a 7.0±0.4a 100
5 3.5±0.2 3.9±0.3b 3.9±0.4b 3.9±0.2b 55.7
6 3.4±0.2 4.6±0.3 4.0±0.2b 4.2±0.3b 60.0
7 3.6±0.3 3.9±0.4b 3.6±0.3b 4.1±0.2b 58.6
8 3.1±0.1 5.0±0.2a 4.9±0.3a,b 5.9±0.5a 84.3
9 3.3±0.3 3.7±0.2b 3.8±0.3b 4.0±0.3b 57.1
10 3.4±0.3 3.1±0.3b 4.6±0.4b 5.7±0.2a,b 81.4
11 3.4±0.3 4.8±0.5a 4.8±0.4b 4.8±0.2a,b 68.6
12 3.4±0.3 4.6±0.3 4.0±0.4b 3.8±0.3b 54.3
13 3.4±0.2 3.8±0.2b 3.4±0.2 3.5±0.4b 50.0
14 3.3±0.3 6.1±0.4a 5.6±0.2a 5.7±0.3a,b 81.4
15 3.3±0.3 4.2±0.4 3.9±0.2b 4.5±0.3b 64.3

Notes: Values represent means ± SE of six rats for each group. aP<0.05 vs control (LSD followed by Dunnett’s test); bP<0.05 vs parent compound (LSD followed by Dunnett’s test). All compounds were dissolved in DMSO (5 mg/kg orally), and the parent compound was also dissolved in DMSO (2.5 mg/kg orally).